Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Sandercock

Showing results (11-20 of 136) with videos related to

Pageof 14
Sort By:
Lancet (London, England)|July 31, 2002
A fainting mechanicPeter Sandercock
Cerebrovascular Diseases (Basel, Switzerland)|April 16, 2011
The authors say: 'The data are not so robust because of heterogeneity' - so, how should I deal with this systematic review? Meta-analysis and the clinicianPeter Sandercock
Cerebrovascular Diseases (Basel, Switzerland)|August 10, 2010
The Johann Jakob Wepfer Award 2010 of the European Stroke Conference to Professor Jan van GijnPeter Sandercock
The Lancet. Neurology|August 7, 2010
Vitamin B supplements for prevention of strokePeter Sandercock
Stroke|August 5, 2006
Sex-based differences in the effect of intra-arterial treatment of stroke: a plea to stop torturing the old data and do large trials!Peter Sandercock, Steff Lewis
Stroke|February 8, 2003
In-hospital care pathways for stroke: a Cochrane systematic reviewJoseph Kwan, Peter Sandercock
Stroke|July 10, 2002
Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischemic stroke (Cochrane review)Carl Counsell, Peter Sandercock
Advances in Neurology|May 23, 2003
Anticoagulants for acute ischemic strokeEivind Berge, Peter Sandercock
British Journal of Haematology|October 8, 2009
Does acetyl salicylic acid (ASA) have a role in the prevention of venous thromboembolism?Gordon Lowe, Peter Sandercock
International Journal of Stroke : Official Journal of the International Stroke Society|January 5, 2018
How to do high-quality clinical research 1: First stepsPeter Sandercock, William Whiteley
Pageof 14

Showing results (11-20 of 136) with videos related to

Sort By:
Pageof 14
Lancet (London, England)|July 31, 2002
A fainting mechanicPeter Sandercock
Cerebrovascular Diseases (Basel, Switzerland)|April 16, 2011
The authors say: 'The data are not so robust because of heterogeneity' - so, how should I deal with this systematic review? Meta-analysis and the clinicianPeter Sandercock
Cerebrovascular Diseases (Basel, Switzerland)|August 10, 2010
The Johann Jakob Wepfer Award 2010 of the European Stroke Conference to Professor Jan van GijnPeter Sandercock
The Lancet. Neurology|August 7, 2010
Vitamin B supplements for prevention of strokePeter Sandercock
Stroke|August 5, 2006
Sex-based differences in the effect of intra-arterial treatment of stroke: a plea to stop torturing the old data and do large trials!Peter Sandercock, Steff Lewis
Stroke|February 8, 2003
In-hospital care pathways for stroke: a Cochrane systematic reviewJoseph Kwan, Peter Sandercock
Stroke|July 10, 2002
Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischemic stroke (Cochrane review)Carl Counsell, Peter Sandercock
Advances in Neurology|May 23, 2003
Anticoagulants for acute ischemic strokeEivind Berge, Peter Sandercock
British Journal of Haematology|October 8, 2009
Does acetyl salicylic acid (ASA) have a role in the prevention of venous thromboembolism?Gordon Lowe, Peter Sandercock
International Journal of Stroke : Official Journal of the International Stroke Society|January 5, 2018
How to do high-quality clinical research 1: First stepsPeter Sandercock, William Whiteley
Pageof 14